ArticleFrontiers in nutrition2026
Association of fat quality index with head and neck cancer risk: results from a prospective study.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As head and neck cancer (HNC) incidence rises, prevention demands attention to diet. Yet most studies emphasize total fat intake while overlooking fat quality. To address this gap, we examined the association between fat quality index (FQI) and HNC risk. Methods: A total of 98,560 participants were included in this study. Hazard ratios (HR) with 95% CIs for overall HNC were estimated using multivariable Cox models. Site-specific analyses were conducted, and fatty-acid components were evaluated. Effect modification was tested across prespecified subgroups. A joint analysis combined FQI tertiles with percent energy from fat. Robustness was assessed through multiple sensitivity analyses. Results: Over a median 8.8 years, 267 HNC cases occurred. Higher FQI significantly reduced overall HNC risk (fully adjusted HR for Quartile 4 vs. Quartile 1: 0.62; 95% CI, 0.42-0.91; P-trend = 0.011), demonstrating a linear inverse dose-response. Findings were consistent across subgroups and sensitivity analyses. By subsite, associations were strongest for laryngeal cancer (HR for Q4 vs. Q1: 0.43; 95% CI: 0.21-0.88). The joint analysis revealed that higher FQI was associated with lower HNC risk even among individuals with high total fat intake (HR = 0.36; 95% CI: 0.21-0.59), with no significant interaction observed. Higher Monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA) intakes were inversely associated with HNC, whereas Saturated fatty acids (SFA) and Trans fatty acids (TFA) were not. Conclusion: Higher FQI is associated with lower HNC incidence, independent of total fat intake. These findings highlight that prioritizing dietary fat quality over quantity may be a critical strategy for HNC primary prevention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.